文献速递产科母胎医学

母体血清果糖胺水平与死产关联的病例对照研究

Maternal serum fructosamine levels and stillbirth: a case-control study of the Stillbirth Collaborative Research Network.
PubMed 文献 · BJOG · 2021-10-14

该研究基于美国五地区多中心病例对照数据,二次分析529例单胎死产与1499例活产产妇。调整混杂因素后,死产组果糖胺均值显著高于活产组(177±3.05 vs 165±2.89 μmol/L,P<0.001),糖尿病产妇差异更大;总体AUC为0.634,糖尿病组0.713,非糖尿病组0.625。结论提示糖尿病孕妇血糖控制可能有益,非糖尿病者差异小不足以支持常规筛查。

要点

  • 死产产妇分娩时果糖胺水平显著高于活产产妇,调整后差异有统计学意义。
  • 糖尿病产妇中死产与活产的果糖胺差异更大,提示血糖控制可能获益。
  • 非糖尿病产妇中差异较小,不足以支持对所有死产常规筛查果糖胺。

核心结论

  • 分娩时母体果糖胺水平在死产产妇中高于活产产妇,糖尿病产妇差异显著,非糖尿病产妇差异小。

研究设计与样本

  • 基于美国五地区多中心病例对照研究的二次分析,纳入529例已知糖尿病状态且有果糖胺测定的单胎死产和1499例代表性活产对照。

主要发现

  • 调整后死产组果糖胺均值177±3.05 μmol/L,活产组165±2.89 μmol/L,P<0.001。
  • 糖尿病产妇中死产组194±8.54 μmol/L,活产组162±3.21 μmol/L;非糖尿病产妇中死产组171±2.50 μmol/L,活产组162±2.56 μmol/L。
  • 果糖胺区分死产的AUC总体0.634(0.605-0.663),糖尿病组0.713(0.624-0.802),非糖尿病组0.625(0.595-0.656)。

临床怎么用

  • 对糖尿病孕妇应重视孕期血糖控制,可能有助于降低死产风险。
  • 非糖尿病孕妇中果糖胺差异较小,不建议对所有死产常规筛查果糖胺。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the association between maternal fructosamine levels at the time of delivery and stillbirth. DESIGN: Secondary analysis of a case-control study. SETTING: Multicentre study of five geographic catchment areas in the USA. POPULATION: All singleton stillbirths with known diabetes status and fructosamine measurement, and representative live birth controls. MAIN OUTCOME MEASURES: Fructosamine levels in stillbirths and live births among groups were adjusted for potential confounding factors, including diabetes. Optimal thresholds of fructosamine to discriminate stillbirth and live birth. RESULTS: A total of 529 women with a stillbirth and 1499 women with a live birth were included in the analysis. Mean fructosamine levels were significantly higher in women with a stillbirth than in women with a live birth after adjustment (177 ± 3.05 versus 165 ± 2.89 μmol/L, P < 0.001). The difference in fructosamine levels between stillbirths and live births was greater among women with diabetes (194 ± 8.54 versus 162 ± 3.21 μmol/L), compared with women without diabetes (171 ± 2.50 versus 162 ± 2.56 μmol/L). The area under the curve (AUC) for fructosamine level and stillbirth was 0.634 (0.605-0.663) overall, 0.713 (0.624-0.802) with diabetes and 0.625 (0.595-0.656) with no diabetes. CONCLUSIONS: Maternal fructosamine levels at the time of delivery were higher in women with stillbirth compared with women with live birth. Differences were substantial in women with diabetes, suggesting a potential benefit of glycaemic control in women with diabetes during pregnancy. The small differences noted in women without diabetes are not likely to justify routine screening in all cases of stillbirth. TWEETABLE ABSTRACT: Maternal serum fructosamine levels are higher in women with stillbirth than in women with live birth, especially in women with diabetes.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Arslan E, Allshouse AA, Page JM, et al. Maternal serum fructosamine levels and stillbirth: a case-control study of the Stillbirth Collaborative Research Network. BJOG. 2021. PMID: 34529344. doi:10.1111/1471-0528.16922

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。